224
Views
13
CrossRef citations to date
0
Altmetric
Research Article

The involvement of serotonin metabolism in cigarette smoke-induced oxidative stress in rat lung in vivo

, , , , &
Pages 1413-1419 | Received 25 May 2012, Accepted 14 Aug 2012, Published online: 10 Sep 2012

References

  • Khalil AA, Davies B, Castagnoli NJr. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Bioorg Med Chem 2006;14:3392–3398.
  • Khalil AA, Steyn S, Castagnoli NJr. Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol 2000;13:31–35.
  • Bacher I, Houle S, Xu X, Zawertailo L, Soliman A, Wilson AA, . Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch Gen Psychiatry 2011;68:817–826.
  • Launay JM, Del Pino M, Chironi G, Callebert J, Peoc'h K, Megnien JL, . Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 2009;4:e7959.
  • Makwana R, Gozzard N, Spina D, Page C.Tumour Necrosis Factor (TNF)-alpha-induced cholinergic airway hyperresponsiveness in guinea-pig airways. Br J Pharmacol 2011. [Epub ahead of print].
  • Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, Sheward J, . Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther 2005;313:539–548.
  • Lau WK, Chan-Yeung MM, Yip BH, Cheung AH, Ip MS, Mak JC, the COPD Study Group of the Hong Kong Thoracic Society.The role of circulating serotonin in the development of chronic obstructive pulmonary disease. PLoS One 2012;7:e31617.
  • Lewis A, Miller JH, Lea RA.Monoamine oxidase and tobacco dependence. Neurotoxicology 2007;28:182–195.
  • Pena-Silva RA, Miller JD, Chu Y, Heistad DD.Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves. Am J Physiol Heart Circ Physiol 2009;297: H1354–H1360.
  • Trouche E, Mias C, Seguelas MH, Ordener C, Cussac D, Parini A.Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev 2010;19: 1571–1578.
  • Domej W, Foldes-Papp Z, Flogel E, Haditsch B.Chronic obstructive pulmonary disease and oxidative stress. Curr Pharm Biotechnol 2006;7:117–123.
  • MacNee W.Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:50–60.
  • Sethi JM, Rochester CL.Smoking and chronic obstructive pulmonary disease. Clin Chest Med 2000;21:67–86, viii.
  • Biernacki WA, Kharitonov SA, Barnes PJ.Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58: 294–298.
  • Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ.Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162: 1175–1177.
  • Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P.Increased content of thiobarbituric acid- reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999;93:389–396.
  • Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, . Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198–1203.
  • Kinnula VL, Ilumets H, Myllarniemi M, Sovijarvi A, Rytila P.8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007;29:51–55.
  • Nicks ME, O’Brien MM, Bowler RP.Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers. Copd 2011;8:264–269.
  • Vibhuti A, Arif E, Deepak D, Singh B, Qadar Pasha MA.Correlation of oxidative status with BMI and lung function in COPD. Clin Biochem 2007;40:958–963.
  • Chan KH, Ho SP, Yeung SC, So WH, Cho CH, Koo MW, . Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med 2009;103:1746–1754.
  • Valenca SS, Silva Bezerra F, Lopes AA, Romana-Souza B, Marinho Cavalcante MC, Lima AB, . Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide. Environ Res 2008;108:199–204.
  • Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, . Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–1313.
  • Lau WK, Chan SC, Law AC, Ip MS, Mak JC.The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cells. Toxicol Sci 2012;125:569–577.
  • Lau WK, Mak JC, Chan KH, Law AC.Cigarette smoke-induced cerebral cortical interleukin-6 elevation is not mediated through oxidative stress. Neurotox Res 2011. [Epub ahead of print].
  • van der Toorn M, Smit-de Vries MP, Slebos DJ, de Bruin HG, Abello N, van Oosterhout AJ, . Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007;293: L1156–L1162.
  • Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W.Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 1995;269:L285–L292.
  • Lentini P, de Cal M, Cruz D, Chronopoulos A, Soni S, Nalesso F, . The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. J Crit Care 2010;25:605–609.
  • Skvarilova M, Bulava A, Stejskal D, Adamovska S, Bartek J.Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:83–87.
  • Pan HZ, Zhang H, Chang D, Li H, Sui H.The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 2008;92:548–551.
  • Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, Spasic S, Vujic T, Stefanovic A, . Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med 2011;105:S31–S37.
  • Mendez-Alvarez E, Soto-Otero R, Sanchez-Sellero I, Lopez-Rivadulla Lamas M.Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Life Sci 1997;60:1719–1727.
  • Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, . Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci USA 2003;100:11600–11605.
  • Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, . Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med 2005;46: 1414–1420.
  • Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, . Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011;66:769–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.